UBS Group »

Pieris Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Pieris Pharmaceuticals (PIRS) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Pieris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pieris Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pieris Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1k 6.3k 0.18
2023-09-30 $13k 44k 0.30
2022-12-31 $2.5k 2.4k 1.04
2022-09-30 $8.0k 6.6k 1.20
2022-06-30 $2.0k 1.0k 1.99
2022-03-31 $67k 22k 3.05
2021-06-30 $4.0k 1.2k 3.46
2021-03-31 $149k 58k 2.57
2020-12-31 $148k 59k 2.51
2020-09-30 $97k 47k 2.06
2020-06-30 $215k 70k 3.09
2020-03-31 $173k 76k 2.27
2019-12-31 $212k 59k 3.62
2019-09-30 $125k 37k 3.41
2019-06-30 $60k 13k 4.70
2019-03-31 $11k 3.2k 3.42
2018-12-31 $80k 30k 2.67
2018-09-30 $70k 13k 5.56
2018-06-30 $33k 6.5k 5.08
2017-12-31 $12k 1.5k 7.84
2017-09-30 $23k 3.9k 5.87
2017-03-31 $4.0k 1.6k 2.55
2016-12-31 $13k 9.0k 1.45
2016-09-30 $3.0k 1.5k 2.07
2015-12-31 $9.0k 4.1k 2.21